argenx SE
$359.82
24H
Market Cap
Volume
Supply
Price Chart
About argenx SE - ARGX
Argenx SE is a biotechnology company that specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. The company is known for its innovative ARGX-113 (efgartigimod) product, among others, which aims to modulate the immune system.
What are argenx SE's core values and mission statement?
Argenx SE's mission is to harness the power of the immune system to improve the lives of people suffering from cancer and severe autoimmune diseases. Their core values revolve around innovation, collaboration, and the commitment to developing life-changing therapies.
Who founded argenx SE and when?
argenx SE was founded by Tim Van Hauwermeiren, Hans de Haard, and Torsten Dreier in 2008.
Who leads argenx SE?
As of the last update, argenx SE was led by Tim Van Hauwermeiren, who serves as the Chief Executive Officer (CEO).
Where is argenx SE located, and what is its base country?
Argenx SE is headquartered in the Netherlands, which is its base country.
On which exchanges is argenx SE traded?
Argenx SE is traded on the NASDAQ under the ticker symbol ARGX and on the Euronext Brussels.
Historical data
argenx SE (ARGX) Price Live Data
The live price of argenx SE (ARGX) is $359.82, with a trading volume of 291,287 in the last 24 hours. Wrapstocks updates the ARGX price in real-time. argenx SE is up 0.39% in the last 24 hours. The company has a live market cap of $21,539,762,176.00 and a supply of 59,862,604 ARGX stocks.
argenx SE (ARGX) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 9 hours and 55 minutes.
